1. Home
  2. PDCO vs MIRM Comparison

PDCO vs MIRM Comparison

Compare PDCO & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDCO
    SELLHOLDBUYas of 15 hours ago
  • MIRM
    SELLHOLDBUYas of 15 hours ago
  • Stock Information
  • Founded
  • PDCO 1877
  • MIRM 2018
  • Country
  • PDCO United States
  • MIRM United States
  • Employees
  • PDCO N/A
  • MIRM N/A
  • Industry
  • PDCO Medical Specialities
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • PDCO Health Care
  • MIRM Health Care
  • Exchange
  • PDCO Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • PDCO 1.9B
  • MIRM 1.9B
  • IPO Year
  • PDCO 1992
  • MIRM 2019
  • Fundamental
  • Price
  • PDCO $30.86
  • MIRM $41.51
  • Analyst Decision
  • PDCO Hold
  • MIRM Strong Buy
  • Analyst Count
  • PDCO 7
  • MIRM 12
  • Target Price
  • PDCO $27.10
  • MIRM $57.58
  • AVG Volume (30 Days)
  • PDCO 1.8M
  • MIRM 368.9K
  • Earning Date
  • PDCO 12-05-2024
  • MIRM 11-12-2024
  • Dividend Yield
  • PDCO 3.37%
  • MIRM N/A
  • EPS Growth
  • PDCO N/A
  • MIRM N/A
  • EPS
  • PDCO 1.72
  • MIRM N/A
  • Revenue
  • PDCO $6,554,872,000.00
  • MIRM $307,028,000.00
  • Revenue This Year
  • PDCO $2.74
  • MIRM $82.14
  • Revenue Next Year
  • PDCO $3.25
  • MIRM $26.18
  • P/E Ratio
  • PDCO $17.92
  • MIRM N/A
  • Revenue Growth
  • PDCO 0.05
  • MIRM 112.14
  • 52 Week Low
  • PDCO $19.45
  • MIRM $23.14
  • 52 Week High
  • PDCO $31.79
  • MIRM $48.89
  • Technical
  • Relative Strength Index (RSI)
  • PDCO 83.63
  • MIRM 43.16
  • Support Level
  • PDCO $30.85
  • MIRM $40.03
  • Resistance Level
  • PDCO $31.07
  • MIRM $43.37
  • Average True Range (ATR)
  • PDCO 0.44
  • MIRM 1.82
  • MACD
  • PDCO 0.62
  • MIRM -0.51
  • Stochastic Oscillator
  • PDCO 91.17
  • MIRM 22.01

Stock Price Comparison Chart: PDCO vs MIRM

PDCO
MIRM
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober05101520253035404550PDCO VS MIRM

About PDCO Patterson Companies Inc.

Patterson Companies Inc is a dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives its revenue from the United States, the United Kingdom, and Canada. The firm derives almost all of its revenue from the United States.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter "IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use